Stevanato Group’s Post

Attending CPHI China is a strategic imperative for pharmaceutical companies involved in API supply and manufacturing. This premier event offers unparalleled networking opportunities, allowing companies to connect with key industry players, potential clients, and strategic partners from around the globe. Additionally, CPHI China showcases the latest advancements in pharmaceutical technology and API manufacturing, providing valuable insights into industry trends and innovations. By participating in this event, companies can stay updated on market developments, discover new products, and integrate cutting-edge solutions into their operations, enhancing efficiency and competitiveness. Moreover, CPHI China serves as a platform to strengthen supplier relationships and boost brand visibility. Face-to-face interactions with existing and potential suppliers facilitate better deals and ensure supply chain reliability. Exhibiting at the event also allows companies to showcase their products and innovations to a global audience, attracting new customers and investors. To maximize these benefits, our specialized travel packages offer convenient travel arrangements, comfortable accommodations, and assistance with event registration, ensuring a seamless and productive experience. Investing in a travel package with us enables pharmaceutical professionals to focus on making the most of CPHI China, driving business growth and securing a competitive edge in the industry. #PharmaIndustry #PharmaInnovation #PharmaLeadership #DrugDiscovery #HealthcareSolutions #PharmaTech #Biopharma #MedicalResearch #PharmaManufacturing #PharmaLife #HealthcareAdvancements #PharmaMarketing #ClinicalTrials #PharmaNews #BioTech #CPHIChina #PharmaNetworking #CPHIBusiness #PharmaInnovation #CPHIExpo #ChinaPharmaMarket #CPHIConnections #PharmaIndustry #CPHIShanghai #PharmaCollaboration #CPHI2024 #PharmaLeaders #CPHIEssentials #PharmaEvents #CPHITradeShow Ajaz Raien Khan Imran

Dr. D.Vijaya Bharathi Bharathi, in her dynamic style, is exploring the various types of impurities and the critical role of synthesis in impurity generation. She is emphasizing how reaction conditions and methodologies impact impurity profiles during her engaging session at the 2nd Annual Pharma Impurity Conclave 2024. #EminenceBusinessMedia #EBMPIC2024 #EminenceGroupVentures

Have you registered yet for the annual European Pharmacovigilance Congress, the industry-leading event gathering PV experts and decision-makers? 💻 Online session: November 18-19 📌 NH Milan Congress Center: November 22 The European Pharmacovigilance Congress, organized by Pharma Education Center PEC is recognized as one of the most important and appreciated global PV conferences, with high-quality scientific content and participants from all over the world. Don't miss out, register here: https://lnkd.in/djFJmc-f #eupvcongress #pharmacovigilance #pharma #lifescience #regulatory #compliance #congress

𝐏𝐨𝐥𝐥: 𝐖𝐡𝐚𝐭 𝐀𝐫𝐞 𝐘𝐨𝐮 𝐌𝐨𝐬𝐭 𝐄𝐱𝐜𝐢𝐭𝐞𝐝 𝐀𝐛𝐨𝐮𝐭 𝐚𝐭 𝐭𝐡𝐞 𝟐𝟏𝐬𝐭 𝐏𝐡𝐚𝐫𝐦𝐚 𝐀𝐬𝐢𝐚 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐄𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐨𝐧 & 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞? We want to hear from you! What are you most looking forward to at the 21st Pharma Asia International Exhibition & Conference? Vote now and let us know! #PharmaAsia #pharmaasia #pharmaasia2024 #ExpoCentreKarachi

AbbVie’s #Humira has long dominated the biosimilar market, but recent data suggests a shift is imminent with a decrease in market share to 82%. Sandoz's #Hyrimoz, a key player, has seen significant gains under the Cordavis co-label, recording a surge in prescriptions after CVS Health Caremark's move to exclude branded Humira from commercial formularies in April. IQVIA data indicates that 82% of Humira biosimilar prescriptions were for Hyrimoz by the end of April, propelling Sandoz to a 6% sales growth in the first quarter. On the other hand, AbbVie's collaboration with Cordavis has resulted in a joint Humira formulation, capturing around 25% of the Cordavis-labelled products market, as per Samsung Bioepis' findings. Meanwhile, Boehringer Ingelheim's #Cyltezo, competing with Humira, faced challenges with only 1,487 prescriptions since its July 2023 launch, compared to Humira's 2.8 million prescriptions during the same period. The delayed uptake led to layoffs within Boehringer's customer-facing team, prompting a shift to a hybrid approach. As AbbVie prepares to transition focus to newer immunology medications like #Skyrizi and #Rinvoq to counter Humira's declining sales – dropping from a record $21.2 billion to $14.4 billion last year – the pharma landscape is evolving rapidly. Skyrizi's recent $2 billion quarterly sales almost matched Humira, which experienced a 40% sales decline in the first quarter. The pharmaceutical market is witnessing dynamic shifts and strategic maneuvers as key players navigate the evolving landscape. ------------- Stay tuned for more insights on PharmaTell Studio or read more on our blog: https://lnkd.in/gTtPWGMk

Honored to be part of the upcoming Annual Global Pharma Regulatory Summit 19-21 June 2024 at Mumbai. Looking forward to connect to the Regulatory community. Hope to see you there. I will be speaking on the topic - Regulatory Intelligence - A Strategic Approach for Evolving Regulatory landscape    #regulatoryintelligence #regulatoryaffairs

Yesterday, we were honoured to be a part of the EU #CriticalMedicinesAlliance launch, represented by 15 of our member CEOs.  We thank them for their commitment and dedication to ensuring a secure supply of medicines in Europe. Over 90% of the EU critical medicines list are essential, #GenericMedicines. They need dedicated policy actions to secure their supply, including: 💊A concrete shortage prevention-strategy 🤝Partnership between the EU and our industry 🔓A shared commitment to ensure access, availability and supply security based on EU solidarity. Read our vision for the EU Critical Medicines Alliance at https://lnkd.in/dG949KJN See our proposal for a critical medicine act at  https://lnkd.in/dgt65ahU Elisabeth Stampa, Medichem, S.A. - Rebecca Guntern, Sandoz - Markus Sieger, Polpharma - Steffen Saltofte, Zentiva - Philippe Drechsle, Teva Pharmaceuticals - Martha Christopoulou, Baxter International Inc. - Stephan Eder, STADA Group - Artur Cwiok, Viatris - Csaba Poroszlai, Egis Pharmaceuticals PLC - Bruno Belli, Fresenius Kabi - Lucas Sigman, Insud Pharma - THEODOROS TRYFON, Elpen Pharmaceutical Co. Inc., Πανελλήνια Ένωση Φαρμακοβιομηχανίας (ΠΕΦ) - PEF - Andreas Loizou, Medochemie Ltd Adrian van den Hoven - Giuliana Pennisi European Commission Belgian Presidency of the Council of the European Union 2024 #AccessForAll #LevellingUp

I was thrilled to be part of such crucial first step towards a Critical Medicines Act. Indeed, we need to complement the #PharmaLegislation with a strong toolkit to tackle #medicineShortages that are adversely affecting patients across Europe. Under the auspices of the European Commission President Ursula von der Leyen the Belgian Presidency of the Council of the European Union 2024 led by Frank Vandenbroucke, Deputy Prime Minister and Minister of Social Affairs and Public Health, along with Commissioner for Health Stella Kyriakides and EU 27 Ministers of Health, the EU #CriticalMedicinesAlliance was officially launched. 15 CEOs representing Medicines for Europe presented our comprehensive approach to secure medicine supplies: 💊 A concrete shortage prevention strategy that includes EU medicines procurement guidelines rewarding security of medicine supply as well as the use of existing IT systems to predict and prevent shortages (such as the serialization system). 🤝 Collaboration between the EU and industry to enhance EU manufacturing competitiveness through digital and environmental innovations in production technologies. This can be facilitated through State Aids and IPCEI initiatives for off-patent medicines. 🔓 Concrete EU 27 solidarity should be our health mantra to deliver equity of access across EU Member States. We must avoid national stockpiling mandates, as they could result in oversupply in larger countries and shortage risks in smaller ones. According to the IQVIA MIDAS database, the German 6-months stockpile is equal to 10 Member Staes annual consumption and stockpile combined (see infographic below). We are ready to further collaborate with EU Institution, Member States and health stakeholders. Action is needed now! 💪🏼 #MedsSecurity #AccessEquity #LevelUP #EUhealthUnion #EUsolidarity #EU2024BE

A massive thank you to Nigel Cryer FRSC for Chairing Temperature Control & Logistics North America last week. As Alan Kennedy explains, Nigel’s leadership set the stage for insightful discussions, collaborative problem-solving, and the introduction of game-changing initiatives across the three days of the event. Pharma IQ would also like to take this opportunity to express our appreciation to all the incredible speakers, sponsors, and attendees who contributed to the success of the event. Your active participation and dedication to innovation in pharmaceutical logistics is what makes these events so impactful. From thought-provoking case studies to actionable takeaways on sustainability, packaging solutions, and regulatory compliance, this year’s event brought together the best minds in the industry, all focused on driving the future of pharma logistics. Thank you to everyone who helped make this event possible! Keep your eyes peeled 👀 for what comes next! In the meantime, don't forget that next week, Pharma IQ is in Europe for the AI in Pharma & Healthcare Summit, where we’ll dive into AI-driven innovations transforming the pharma industry: https://lnkd.in/eUkG-4fZ Maité Pereyra Amelia Reeks Nikki Kandola Charlotte H. Gal Cohen Harry Lawrence James Mason Daniel Buldhoo Hayley Atkinson Checkit (LSE: CKT) EMBALL'ISO InTemp Monitoring Solutions by Onset #pharmaiq #pharmalogistics #pharmasupplychain #Sustainability #PharmaInnovation #TemperatureControlLogistics #AIPharma #Pharmatransformation #AIHealthcare

Thoughts on this? >> BeiGene looks beyond China as it secures new API source, nears opening of US site >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharma #pharmaceutical